296 / 1084
Surgery vs. neoadjuvant chemotherapy + surgery
Pennathur et al, Lancet 2013
•
Rationale: control early spread of systemic disease
•
Results not consistent
•
MAGIC study (Cunningham) may not be generalisable to all
esophageal adenocarcinoma (26% EGJ/adeno)